Jeffrey William Jacobs

USPTO Granted Patents = 43 (Patent Applications = 14)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 15 (Patent Applications = 14)

Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 465(Granted Patents)

Location History:

San Mateo, CA (US) (1994 - 2021)
Fremont, CA (US) (2015 - 2024)

Company Filing History:

Sunesis Pharmaceuticals, Inc.

patents

4 out of 23

Vicuron Pharmaceuticals Inc.

Affymax Technologies, N.v.

University of Colorado

patents

Years Active: 1994-2024

Loading Chart...

43 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12084472 - Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists (2024-09-10),

2. 12016856 - Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders (2024-06-25),

3. 11813304 - Compounds and methods for inhibiting phosphate transport (2023-11-14),

4. 11318129 - Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders (2022-05-03),

5. 10968246 - Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists (2021-04-06),

6. 10940146 - NHE3-binding compounds and methods for inhibiting phosphate transport (2021-03-09),

7. 10543207 - Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders (2020-01-28),

8. 10392413 - Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists (2019-08-27),

9. 10385024 - Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders (2019-08-20),

10. 10376481 - Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders (2019-08-13),

11. 10272079 - NHE3-binding compounds and methods for inhibiting phosphate transport (2019-04-30),

12. 9919006 - Compositions and methods for treating hyperkalemia (2018-03-20),

13. 9867848 - Compositions and methods for treating hyperkalemia (2018-01-16),

14. 9676774 - Compounds and compositions for treatment of cancer (2017-06-13),

15. 9655921 - Compositions and methods for treating hyperkalemia (2017-05-23),

Title: The Innovative Journey of Jeffrey William Jacobs

Introduction: Jeffrey William Jacobs, a visionary inventor based in San Mateo, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Jeffrey William Jacobs holds several patents in the areas of artificial intelligence, renewable energy, and medical devices. His most recent patent involves a revolutionary AI-powered healthcare monitoring system that has the potential to transform the way patients receive care.

Career Highlights: With a background in engineering and a passion for innovation, Jeffrey William Jacobs has led successful projects in both the corporate and startup sectors. His ability to blend creativity with technical expertise has led to the development of cutting-edge solutions that address real-world challenges.

Collaborations: Throughout his career, Jeffrey William Jacobs has collaborated with leading researchers, engineers, and industry experts to bring his inventions to life. His collaborative spirit and dedication to excellence have been instrumental in the success of many projects.

Conclusion: Jeffrey William Jacobs continues to push the boundaries of innovation, with a focus on creating technologies that have a positive impact on society. His relentless pursuit of excellence and commitment to making a difference make him a true pioneer in the world of invention.

This text is generated by artificial intelligence and may not be accurate.